Skip to main content
The Egyptian Journal of Internal Medicine
Download PDF
  • Original article
  • Open access
  • Published:

Modifiable cardiovascular risk factors in patients with Behçet’s disease: a multicenter experience

The Egyptian Journal of Internal Medicine volume 31, pages 726–732 (2019)Cite this article

Abstract

Background

Vascular involvement in Behçet’s disease (BD) is one of the major causes of mortality and morbidity. Modifiable cardiovascular risk factors such as high blood pressure, dyslipidemia, hyperglycemia, overweight, and smoking have been demonstrated to have a significant impact on cardiovascular disease in the general population with or without other diseases.

Objective

The aim of this study was to evaluate whether modifiable cardiovascular disease risk factors differ among patients with BD in comparison with the general population.

Patients and methods

This was a multicenter case–control study carried out on 182 BD patients identified by analysis of the databases of the International Study Group Classification Criteria. The patients were compared with 80 controls matched for age, sex, and study period. Full clinical history taking and medical examination were carried out for all patients, and investigations including lipid profile and blood glucose were carried out and data on hypertension, height, weight, and smoking were collected and recorded.

Results

Levels of serum low-density lipoprotein (P<0. 005) and cholesterol (P<0.005) were significantly high in the Behçet patient group, but no statistical difference was detected as regards triglycerides, diabetes mellitus, or BMI. Smoking and hypertension increase the risk of cardiovascular manifestations in our patients. The mean±SD age of BD patients was 31.6±9.008, 76.9% were male individuals and 23.1% were female individuals.

Conclusion

Patients with BD had a high prevalence of cardiovascular comorbidities. Optimal control of blood pressure, lipids and blood sugar with reduction in body weight and stoppage of smoking may be an effective strategy to reduce vascular complications in these populations.

References

  1. Hasan MS, Ryan PL, Bergmeier LA, Fortune F. Circulating NK cells and their subsets in Behçet’s disease. Clin Exp Immunol 2017; 188:311–322.

    Article  CAS  Google Scholar 

  2. Cho SB, Cho S, Bang D. New insights in the clinical understanding of Behçet’s disease. Yonsei Med J 2012; 53:35–42.

    Article  CAS  Google Scholar 

  3. Demirelli S, Degirmenci H, Inci S. Cardiac manifestations in Behcet’s disease. Intractable Rare Dis Res 2015; 4:70–75.

    Article  Google Scholar 

  4. Alibaz-Oner F, Direskeneli H. Management of vascular Behcet’s disease. Int J Rheum Dis 2019; 1:105–108.

    Article  Google Scholar 

  5. Yazici H, Seyahi E, Hatemi G. Behçet syndrome: a contemporary view. Nat Rev Rheumatol 2018; 14:107–117.

    Article  CAS  Google Scholar 

  6. Cocco G, Gasparyan AY. Behçet’s disease: an insight from a cardiologist’s point of view. Open Cardiovasc Med J 2010; 4:63–70.

    PubMed  PubMed Central  Google Scholar 

  7. Zeidan MJ, Saadoun D, Garrido David M. Behcet’s disease physiopathology: a contemporary review. Auto Immun Highlights 2016; 7:4

    Article  Google Scholar 

  8. El-Gazzar I, El-Dakrony AH, Sayed S. Clinical significance of metabolic syndrome and carotid intima-media thickness in Behçet’s disease patients: relation to disease activity. Egypt Rheumatol 2017; 39:171–174.

    Article  Google Scholar 

  9. Sundström B, Johansson G, Johansson I. Modifiable cardiovascular risk factors in patients with ankylosing spondylitis. Clin Rheumatol 2014; 33:111–117.

    Article  Google Scholar 

  10. Pandey A, Garg J, Krishnamoorthy P. Predictors of coronary artery disease in patients with Behcet’s disease. Cardiology 2014; 129:203–206.

    Article  CAS  Google Scholar 

  11. Kechida M, Salah S, Kahloun R. Cardiac and vascular complications of Behçet disease in the Tunisian context: clinical characteristics and predictive factors. Adv Rheumatol 2018; 58:32.

    Article  Google Scholar 

  12. Ayari J, Mourali MS, Farhati A, Mechmeche R. Left main coronary artery thrombosis revealing angio-Behçet syndrome. Egypt J Intern Med 2014; 26:88–90.

    Article  Google Scholar 

  13. Gheita TA, El-Latif EA, El-Gazzar II. Behçet’s disease in Egypt: a multicenter nationwide study review of the literature. Clin Rheumatol 2019; 38:1–11.

    Article  Google Scholar 

  14. Davatchi F. Behcet’s disease. Int J Rheum Dis 2014; 17:355–357.

    Article  Google Scholar 

  15. El Menyawi MM, Raslan HM, Edrees A. Clinical features of Behcet’s disease in Egypt. Rheumatol Int 2009; 29:641–646.

    Article  Google Scholar 

  16. Sula B, Batmaz I, Ucmak D. Demographical and clinical characteristics of Behcet’s disease in Southeastern Turkey. J Clin Med Res 2014; 6:476–481.

    PubMed  PubMed Central  Google Scholar 

  17. Kim JH, Jeong MH. Can family history of premature coronary artery disease be a risk factor for clinical outcomes in patients with acute myocardial infarction?. Korean J Intern Med 2013; 28:538–540.

    Article  Google Scholar 

  18. Aksu T, Güler E, Arat N. Cardiovascular involvement in Behçet’s disease. Arch Rheumat 2015; 30:109–115.

    Article  Google Scholar 

  19. Wu CY, Yu HS, Chai CY. Increased ischemic stroke risk in patients with Behcet’s disease: a nationwide population based cohort study. PLoS ONE 2019; 14:e0218652.

    Article  CAS  Google Scholar 

  20. Koca SS, Kara M, Özgen M. Low prevalence of obesity in Behçet’s disease is associated with high obestatin level. Eur J Rheumatol 2017; 4:113–117.

    Article  Google Scholar 

  21. Pancar GS, Kalkan G. Diagnostic value of HbA1c level in Behcet’s disease and evaluation of neutrophil-lymphocyte ratio, mean platelet volume and body mass index. J Hematol 2015; 4:219–222.

    Article  CAS  Google Scholar 

  22. Erdem H, Dinc A, Pay A. Peripheral insulin resistance in patients with Behçet’s disease. Eur Acad Dermatol Venereol 2006;391–395

  23. Hassan S, Gheita T, Ghoneim S. Subclinical atherosclerosis in Behçet’s disease. Turk J Rheumatol 2012; 27:109–114.

    Article  Google Scholar 

  24. Messedi M, Jamoussi K, Frigui M. Atherogenic lipid profile in Behçet’s disease: evidence of alteration of HDL subclasses. Arch Med Res 2011; 42:211–218.

    Article  CAS  Google Scholar 

  25. Seyahi E, Ugurlu S, Cumali R. Atherosclerosis in Behçet’s syndrome. Semin Arthritis Rheum 2008; 38:1–12.

    Article  CAS  Google Scholar 

  26. Kayatas K, Karatoprak C, Cebeci F. Presence of low lipid levels in patients with Behcet’ s disease as a protector against atherosclerosis. Eur Rev Med Pharmacol Sci 2013; 17:2330–2334.

    CAS  PubMed  Google Scholar 

  27. Lee SS, Choi CB, Lee EK. The association between smoking and clinical manifestations in patients with Behcet’s disease. Korean J Med 2008; 75:202–209

    Google Scholar 

  28. Malek Mahdavi A, Khabbazi A, Yaaghoobian B. Cigarette smoking and risk of Behcet’s disease: a propensity score matching analysis. Mod Rheumatol 2018; 29:1439–7595.

    Google Scholar 

  29. Ridker PM, Hennekens CH, Buring JE. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. New Engl J Med 2000; 342:836–843.

    Article  CAS  Google Scholar 

  30. Muftuoclu A, Yazici H, Yurdakul S. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 1986; 25:235–239.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine, Rheumatology& Immunology Division, Department of Internal Medicine, Faculty of Medicine, Menoufia University, Shebin-Elkom, Menoufia, 32511, Egypt

    Emad El-Shebiny MD, Amira El-Fakharany, Enas Zahran & Sabry Shoeib

  2. Rheumatology and Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt

    Mohamed Salem

  3. Rheumatology and Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Tanta University, Tanta, Egypt

    Mohammed Elnaggar

  4. Rheumatology and Immunology Unit, Department of Internal Medicine, Faculty of Medicine, Mansoura University, Mansoura, Egypt

    Nibal Morad

Authors
  1. Emad El-Shebiny MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amira El-Fakharany
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Enas Zahran
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sabry Shoeib
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohamed Salem
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mohammed Elnaggar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Nibal Morad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Emad El-Shebiny MD.

Additional information

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

El-Shebiny, E., El-Fakharany, A., Zahran, E. et al. Modifiable cardiovascular risk factors in patients with Behçet’s disease: a multicenter experience. Egypt J Intern Med 31, 726–732 (2019). https://doi.org/10.4103/ejim.ejim_112_19

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejim.ejim_112_19

Keywords